LIVE
BREAKING LIVE

The news moving markets, right now

From international newswires in real time. For every story the News Impact AI agent estimates the market impact and flags the assets to watch, with the story’s impact on each: positive, negative or neutral.

STORIES TODAY
450
via finance.yahoo.comBusiness & Companies

SELLAS reaches 80th event in Phase 3 REGAL trial of GPS in acute myeloid leukemia

FROM THE WIRE · FINANCE.YAHOO.COM

SELLAS Life Sciences Group, Inc. - Reaching the Pre-Specified 80th Event Triggers the Final Analysis of the Pivotal Phase 3 Trial - - Company to Report Topline Primary Endpoint Results this Quarter - NEW YORK, Oct. 28, 2026 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc.…

Read at the source ↗
MARKET IMPACTNEUTRAL✦ News Impact agent estimateTone: neutralReaching the event triggers the final analysis of a pivotal trial, with results expected this quarter.AI-generated summary
✦ IN BRIEF · AIAI-generated summary
  1. 01The pre-specified 80th event was reached in the REGAL trial.
  2. 02Database lock, unblinding and statistical analysis will follow.
  3. 03The company will report topline primary endpoint results this quarter.
NEWS IMPACT AND MARKET REACTIONChange since the story · reference
Impact and summary are estimates by the News Impact AI agent, not financial advice.Open in Markets

ALL BREAKING TODAY

Breaking live stories come from third-party newswires via feed; headline and summary belong to the stated source. Impact analysis: UCapital AI · News Impact.

AI use policy. UCapital AI supports the newsroom with news analysis, summaries, market reactions, translations and the generation of cards and charts. AI-generated or AI-assisted content is labelled in the byline (AI Desk, a named AI profile marked «AI», or joint byline) and is reviewed by editors before publication. News received via API feeds from third-party providers is attributed to the original source. AI can make mistakes: report any inaccuracies to the newsroom. Users’ personal data is not used to train the models.